Galaxy Surfactants Ltd Q4 FY2023 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/17ovqz412pexnixnegyunev9.pdf

Key Takeaways


Demand Environment

Natarajan Krishnan: "Recession, as our customers say that it can be like for a shorter time and at a lower level. That's what they indicate even if that happens, but the main issue is in terms of they have to resolve this debt ceiling stuff."

Specialty Care: The Drag & Recovery Path


Margin & Mix Execution


Anti-Dumping Duty on Lauric Acid

Unnathan Shekhar: "So it's not that we have just accepted it because any such levy, which is inflationary, is something that we need to contest, and we firmly believe this is unjust."

Regional & Segment Dynamics

Region / SegmentTrendCommentary
India▲ StrongMajorly tilted toward mass and masstige; rural demand making a comeback; urban remains the major growth portion; new HPC entrant adds tailwind.
Performance Surfactants▲ 12% volume growthLargely driven by domestic India; mix and risk management supported realization.
AMET ex-Egypt▬ Stabilizing7% volume growth momentum sustaining; currency stability emerging after two years of pressure.
Egypt▼ Weak, recoveringVolumes stabilizing; growth expected back by H2 FY24.
U.S.▼ Weak, near-turnSix months of destocking nearing end; demand expected from Q2 FY24.
Europe▼ Weak, prolongedConsumer trade-down to mass/masstige products; pain will be longer.
Specialty Care▼ DeclinedTriple hit from freight, trade-down, and destocking; U.S.-led recovery expected from Q2.
Unnathan Shekhar: "Whereas in the U.S., we would like to believe that the inventory destocking, which has been going on for the last almost 6 months, will likely stop by the end of this quarter... The pain, we believe, in Europe will be longer."

Capex & Capacity


Guidance & Commitments

CommitmentSpecificsTimeline
India volume growth8% to 10% across segmentsNext 3 to 5 years
Global consolidated volume growth6% to 8%Ongoing
EBITDA growthHigher than volume growthOngoing
PAT growthHigher than EBITDA growthOngoing
ROCEIn the 22% zoneOngoing
U.S. demand recoveryDestocking ends, demand returnsQ2 FY24
Egypt growth recoveryGrowth should come backH2 FY24
Annual capexINR150–170 croresFY24
Performance-to-specialty proportionAround 2/3, 1/3 zoneOngoing
Anti-dumping duty on lauric acidAny levies will finally get passed on to consumersWhen equilibrium establishes

Key Metrics

MetricQ4 FY23
Volume growth target (global consolidated)6% to 8%
Volume growth target (India domestic, 3-5 year outlook)8% to 10%
Performance surfactants volume growth12% for the quarter
AMET region volume growth (ex-Egypt)7%
Performance to specialty volume proportion2/3, 1/3
Specialty care revenueroughly INR245 crores, down from INR400 crores in Q3
Other expenditureINR117 crores, down from INR147 crores in Q1, majorly due to freight cost reduction
Lauryl alcohol price$1,350 to $1,400 per tonne, down from $2,000–$2,200 in early FY23
Fatty alcohol price correction (last 12 months)50%
Fatty alcohol price change (Q4 vs Q3)flat
Fatty alcohol as share of raw material purchases50% to 55%
ROCE target22% zone
Maintenance capex₹30 crores to ₹40 crores per annum
Capex guidance₹150 crores per annum, or roughly ₹150 crores to ₹170 crores for the next year
Cash and bank balancealmost INR150 crores
Total trading capacity440,000 tonnes
FY23 volumesaround 220,000 tonnes
Average capacity utilizationabout 65%
EBITDA per tonne increase (from prior average)from INR16,000–INR17,000 to around INR24,000–INR25,000
Performance surfactants realization (per an analyst's math)about INR115 per kg (based on FY21 levels)
Specialty care realization (per an analyst's math)INR140 to INR150